Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
38.72
+1.28 (3.42%)
Jun 30, 2026, 12:56 PM EDT - Market open
Celldex Therapeutics Employees
Celldex Therapeutics had 198 employees as of December 31, 2025. The number of employees increased by 12 or 6.45% compared to the previous year.
Employees
198
Change (1Y)
12
Growth (1Y)
6.45%
Revenue / Employee
$4,369
Profits / Employee
-$1,432,556
Market Cap
3.04B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 198 | 12 | 6.45% | 198 | 0 |
| Dec 31, 2024 | 186 | 26 | 16.25% | 186 | 0 |
| Dec 31, 2023 | 160 | 12 | 8.11% | 160 | 0 |
| Dec 31, 2022 | 148 | 14 | 10.45% | 148 | 0 |
| Dec 31, 2021 | 134 | 9 | 7.20% | 132 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Vericel | 398 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 339 |
| Nurix Therapeutics | 317 |
| Biohaven | 274 |
| Disc Medicine | 154 |
| Pharvaris | 134 |
CLDX News
- 5 days ago - Celldex Therapeutics Transcript: AGM 2026 - Transcripts
- 16 days ago - Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting - GlobeNewsWire
- 16 days ago - Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting - GlobeNewsWire
- 19 days ago - Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress - GlobeNewsWire
- 4 weeks ago - Celldex Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Celldex Reports First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Celldex Therapeutics Earnings release: Q1 2026 - Filings
- 7 weeks ago - Celldex Therapeutics Quarterly report: Q1 2026 - Filings